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DOI 10.1186/s12884-015-0776-9RESEARCH ARTICLE Open AccessUrinary protein-to-creatinine ratio in
pregnant women after dipstick testing:
prospective observational study
Yosuke Baba1, Takahiro Yamada2*, Mana Obata-Yasuoka3, Shun Yasuda4, Yasumasa Ohno5, Kosuke Kawabata6,
Shiori Minakawa7, Chihiro Hirai8, Hideto Kusaka9, Nao Murabayashi10, Yusuke Inde11, Michikazu Nagura12,
Hiromi Hamada3, Atsuo Itakura8, Akihide Ohkuchi1, Makoto Maeda9, Norimasa Sagawa12, Akihito Nakai11,
Soromon Kataoka6, Keiya Fujimori4, Yoshiki Kudo7, Tomoaki Ikeda10 and Hisanori Minakami2Abstract
Background: The dipstick test is widely used as a primary screening test for detection of significant proteinuria in
pregnancy (SPIP). However, it often shows a false positive test result. This study was performed to determine which
pregnant women should be recommended to undergo determination of urinary protein-to-creatinine ratio (mg/mg,
P/Cr test) after dipstick test for confirmation of SPIP.
Methods: This was a multicenter, prospective, and observational study of 2212 urine specimens from 1033 pregnant
women who underwent simultaneous dipstick and P/Cr tests in the same spot urine samples at least once. SPIP was
defined as P/Cr > 0.27. Preeclampsia was diagnosed in women with both hypertension and SPIP.
Results: Preeclampsia, hypertension alone, and SPIP alone developed in 202 (20 %), 73 (7.1 %), and 120 (12 %) women,
respectively. Creatinine concentration [Cr] varied greatly, ranging from 8.1 to 831 mg/dL in the 2212 urine samples.
Rate of positive dipstick test results increased with increasing [Cr], while SPIP prevalence rate was lower in urine
samples with higher [Cr], yielding higher false positive rates in samples with higher [Cr]. Postpartum urine samples had
significantly lower [Cr] compared to those obtained antepartum (60 [8.7–297] vs. 100 [10–401] mg/dL, respectively). At
the first P/Cr test among women with similar dipstick test results, the risk of having SPIP was consistently and
significantly higher for hypertensive women than for normotensive women at any dipstick test result: 18 % (14/77) vs.
3.2 % (8/251), 47 % (26/55) vs. 8.7 % (37/425), 91 % (82/90) vs. 59 % (44/75) for negative/equivocal, 1+, and≥ 2+ test
results, respectively. The risk of SPIP was 16 % (9/55) for normotensive women when two successive antenatal urine
samples showed a dipstick test result of 1 + .
Conclusions: For prediction of SPIP, the dipstick test was more likely to show a false positive result in concentrated
urine samples with higher [Cr]. Hypertensive women with≥ 1+ as well as normotensive women with≥ 2+ on dipstick
test should be advised to undergo the P/Cr test.
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Preeclampsia (PE) is a life-threatening complication for
both the mother and fetus [1]. As PE is usually diag-
nosed in women that developed both hypertension and
significant proteinuria in pregnancy (SPIP), assessment
of proteinuria is an important constituent of antenatal
care for pregnant women. The dipstick test is widely
used in screening for SPIP, but concerns have been
raised regarding its accuracy [2–8]. Both false negative
and positive results can occur on dipstick test for predic-
tion of SPIP [2–10]. The dipstick test is designed to
reflect urinary protein concentration [P] at a certain cut-
off level not corrected by urinary creatinine concentra-
tion [Cr]; dipsticks with ≥ 1+ on visual judgment for
urinary protein concentration ≥ 30 mg/dL are widely
used in Japan [9]. It has been suggested that negative
and positive dipstick test results are likely to occur in di-
luted and concentrated urine samples with lower and
higher creatinine concentrations, respectively, regardless
of actual daily protein loss in the urine [9].
The golden standard test for determination of SPIP
is confirmation of urinary protein loss ≥ 0.3 g/day in
urine collected for 24 h (24-h urine test). However,
the 24-h urine test is inconvenient for both pregnant
women and obstetric service providers, and it is
sometimes difficult for pregnant women to collect 24-
h urine accurately [9, 11]. As daily creatinine produc-
tion reflects muscle mass and creatinine is eliminated
solely by renal excretion, 24-h urinary creatinine ex-
cretion reflects muscle mass and excretion is rela-
tively constant over time in a given person [12],
ranging from 11.0 mg/kg/day to 25.0 mg/kg/day [11].
Use of the urinary spot protein-to-creatinine ratio (P/
Cr test) is currently recommended for evaluation of
protein loss per day outside pregnancy [13, 14]. The
Australian Society for the Study of Hypertension in
Pregnancy, the International Society for the Study of
Hypertension in Pregnancy, and the Japan Society of
Obstetrics and Gynecology have proposed use of the
P/Cr test as an alternative to 24-h urine collection
[15–17], and a threshold of 30 mg/mmol (0.265 mg/
mg) is recommended [15–18]. In Japan, confirmation
by P/Cr test is recommended in pregnant women
with dipstick test results ≥ 1+ in the presence of
hypertension, ≥1+ on two successive antenatal care
visits, and ≥ 2+ even in the absence of hypertension
[17]. However, the rationale for this recommendation
has not been examined in detail. Thus, it is unclear
which pregnant women should be recommended to
undergo confirmation of SPIP with P/Cr test after
obtaining positive dipstick test results.
This multicenter prospective observational study was
conducted to determine the predictive capability of the
dipstick test for SPIP in pregnant women in variousclinical situations and which pregnant women should be
recommended to undergo determination of urinary
protein-to-creatinine ratio (mg/mg, P/Cr test) after dip-
stick test for confirmation of SPIP.
Methods
This prospective observational study was conducted
after receiving approval from the Institutional Review
Board of Hokkaido University Hospital (013–0399, April
30, 2014). The following 12 facilities located throughout
Japan participated in this study: Hiroshima University
Hospital (HUH, Hiroshima), Rakuwakai Otowa Hospital
(ROH, Kyoto), Ohno Ladies Clinic (OLC, Nagoya), Mie
Chuo Medical Center (MCMC, Tsu), Mie University
Hospital (MUH, Tsu), Nippon Medical School Tama
Nagayama Hospital (NMSTNH, Tokyo), Juntendo
University Hospital (JUH, Tokyo), University of Tsukuba
Hospital (UTH, Tsukuba), Jichi Medical University
Hospital (JMUH, Shimotsuke), Fukushima Medical
University Hospital (FMUH, Fukushima), Hakodate
Central General Hospital (HCGH, Hakodate), and
Hokkaido University Hospital (HoUH, Sapporo).
Participants
A total of 6984 women gave birth at gestational week
(GW) ≥ 22 during the one-year study period between
April 1, 2014, and March 31, 2015, in the 12 facilities.
Of the 6984 women, 1033 (15 %) underwent simultan-
eous dipstick test and P/Cr test in the same spot urine
specimens at least once, and were enrolled in this study.
All 1033 participants gave verbal informed consent to
the participation in this study after opening details of
this study to the public via the website of Hokkaido
University Hospital in June 2014.
Various information was collected regarding these 1033
women, i.e., maternal age, experience of prior birth, gesta-
tional week (GW) at simultaneous dipstick and P/Cr tests
with results of those tests, development of hypertension,
GW at delivery, delivery mode, infant birthweight, and
reasons for the first performance of P/Cr test that were
classified into the following seven categories according to
dipstick test results and the presence or absence of hyper-
tension: (1) negative or equivocal dipstick test results in
the presence of hypertension, (2) positive dipstick test re-
sult (1+) in the presence of hypertension, (3) positive dip-
stick test result (≥2+) in the presence of hypertension, (4)
negative or equivocal dipstick test results in the absence
of hypertension, (5) positive dipstick test result (1+) in the
absence of hypertension, (6) positive dipstick test result
(≥2+) in the absence of hypertension, (7) positive dipstick
test result (1+) on two successive antenatal care visits in
the absence of hypertension.
SPIP was defined as a P/Cr (mg/mg) test result of >
0.27. Hypertension was defined as the occurrence of
Table 1 Demographic characteristics of 1033 participants
Number of study subjects 1033
Maternal age (yr) 33 (16–49)
Nulliparity 583 (56.4 %)
Twin pregnancy 95 (9.2 %)
Gestational hypertension 73 (7.1 %)
SPIP alone 120 (11.6 %)
Preeclampsia 202 (19.6 %)
Gestational week at delivery for singletons 38.4 (23.7–42.3)
Birthweight for singletons (g) 2872 (369–4645)
Gestational week at delivery for twins 37 (24.3–40)
Birthweight for twins (g) 2282 (125–3276)
Caesarean delivery for singletons 433 (46.1 %)
Caesarean delivery for twins 82 (97.6 %)
Total number of P/Cr testsa 2212
Number of P/Cr tests/person 2 (1–5)
Antenatal P/Cr testa alone 826 (79.9 %)
Postnatal P/Cr testa alone 29 (2.8 %)
Both of the above 178 (17.2 %)
Data are presented as the median (range) or number (percentage)
SPIP, significant proteinuria in pregnancy defined as P/Cr > 0.27;
awith simultaneous dipstick test
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nosed in women that showed both hypertension and
SPIP. PE was also diagnosed in women with chronic
hypertension when SPIP occurred on and after GW 20.
Gestational hypertension was defined as a new onset of
hypertension on and after GW 20 in the absence of SPIP
throughout gestation. Chronic hypertension was diag-
nosed in women who were confirmed to have hyperten-
sion before GW 20.
Dipstick test and P/Cr test
Spot urine sampling was not performed at any particular
time of the day, and without any particular time in rela-
tion to meal intake for outpatients. Morning urine was
served for the dipstick and P/Cr tests for inpatients. The
dipstick examination to screen for SPIP was performed
by nurses or midwives. Various types of dipstick were
used, including Combisticks™, Uristicks™, N-Multisticks
SG-L™, Hemacombisticks™, and Lovesticks™ (Siemens
Healthcare Japan Co., Ltd., Tokyo) at nine facilities
(JUH, FMUH, HCGH, OLC, NMTNH, HUH, UTH,
MUH and HoUH), Uropaper III™ (Eiken Chemical Co.,
Ltd., Tokyo) at two facilities (JMUH and ROH), and
Meditape II 9U™ (Arkray Inc., Kohga, Japan) at one facil-
ity (MCMC). Most dipsticks used in this study are likely
to show a false positive test result in urines with high
specific gravity, urines of alkaline with pH ≥ 8.0, and or
urines contaminated with quaternary ammonium salt or
antiseptic such as a chlorhexidine, and a false negative
result in acidic urines with pH ≤3.0 according to manu-
facturer's instructions. The attending physicians at each
facility ordered the P/Cr test in the same spot urine spe-
cimen with a dipstick test result at their discretion when
it was considered helpful for patient care. Measurement
of protein concentration ([P], mg/dL) and [Cr] were per-
formed at the institutional central laboratory of each of
the 12 participating facilities.
Data are presented as the median (range). Statistical
analyses were performed using the JMP10© statistical
software package (SAS, Cary, NC). The Wilcoxon/Krus-
kal–Wallis method was used for comparison of medians.
Fisher’s exact probability test was used for comparison
of categorical variables. In all analyses, P < 0.05 was
taken to indicate statistical significance.
Results
SPIP was confirmed in 322 of the 1033 women
(31.2 %) enrolled in the study. Of the 322 women
with SPIP, 202 had hypertension and were diagnosed
with PE, while the remaining 120 women were diag-
nosed as having SPIP alone (Table 1). Seventy-three
(7.1 %) women developed hypertension alone and
were diagnosed with gestational hypertension. A total
of 2212 simultaneous dipstick and P/Cr tests wereperformed antepartum and/or postpartum in the 1033
women (Table 1); only once in 402 women, twice in
207, three times in 339, four times in 46, five times
in 39 women, only antepartum in 826 women, only
postpartum in 29 women, and both ante- and post-
partum in 178 women.
In the 2212 urine specimens, median [Cr] was 105 mg
and varied greatly ranging from 8.7 to 831 mg/dL (Fig. 1).
Median [P] was 17 mg/dL and varied from 0.0 mg/dL to
6170 mg/dL. Concentrated urine samples with [Cr] >
500 mg/dL were collected from women in earlier stages
of pregnancy. Diluted urine with lower [Cr] was signifi-
cantly more common in postnatal urine samples than in
those obtained antenatally (see legend for Fig. 1).
Of the 2212 urine samples from 1033 women, 877
(39.6 %), 934 (42.2 %), 252 (11.4 %), and 149 (6.7 %) were
negative or equivocal, 1+, 2+, and 3+ on dipstick tests, re-
spectively (Table 2). For prediction of SPIP with dipstick
test in this population, false negative test results occurred
in 8.8 % (77/877) of samples, and overall false positive test
results occurred in 59 % (787/1335) of samples. The false
positive rate was 78 % (733/934) for 1+ on dipstick test,
21 % (52/252) for 2+ on dipstick test, and 1.3 % (2/149)
for 3+ on dipstick test. It was notable that [Cr] was signifi-
cantly and consistently higher in urine specimens without
SPIP than in those with SPIP at any dipstick test result. In
addition, [Cr] was higher for urine specimens with stron-
ger positive dipstick test results.
Fig. 1 Protein and creatinine concentrations in 2212 urine samples from
1033 pregnant women. The oblique line differentiates the area of P/Cr >
0.27 (upper area) from P/Cr < 0.27 (lower area). In 2212 spot urine
samples (1924 antenatal urine samples and 288 postnatal urine samples)
from 1033 women, median [Cr] was 105 mg/dL and varied greatly,
ranging from 8.1 to 831 mg/dL. Median [P] (range) was 17 (0.0–6170)
mg/dL. There were 6 urine samples with [Cr] > 500 mg/dL. Five of the 6
urine samples (from 5 women) with [Cr] > 500 mg/dL were collected at
GW 12.7 (8.7–20.3) and the other was at GW 31. The frequency of dilute
urine samples with lower [Cr] was significantly higher among postnatal
than antenatal urine samples: 4.9 % (14/288) vs. 2.1 % (40/1924),
respectively (P= 0.012), for [Cr] < 20 mg/dL; and 9.4 % (27/288) vs. 3.8 %
(73/1924), respectively (P= 0.0001), for [Cr] < 25 mg/dL
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results increased with increasing [Cr], while frequency
of SPIP was lower in urine samples with higher [Cr]
(Fig. 2), clearly indicating that false positive dipstick
test results were likely to occur in concentrated urine
samples with higher [Cr] for prediction of SPIP.Table 2 Relationship between dipstick test results and P/Cr test resu
P/Cr test
Dipstick test results SPIP(%)
Negative/equivocal (n = 877)
SPIP present (n = 77) 8.8
SPIP absent (n = 800)
Positive with 1+ (n = 934)
SPIP present (n = 201) 21.5
SPIP absent(n = 733)
Positive with 2+ (n = 252)
SPIP present (n = 200) 79.4
SPIP absent (n = 52)
Positive with 3+ (n = 149)
SPIP present (n = 147) 98.7
SPIP absent (n = 2)
[P], protein concentration; [Cr], creatinine concentration; SPIP, significant proteinuria
a, P < 0.05 vs. samples without SPIPPostpartum urine samples were more dilute than those
obtained antepartum (Table 3): in the 178 women for
whom both ante- and postnatal urine samples were avail-
able, [Cr] was significantly lower for postnatal urine sam-
ples than for those obtained antenatally. Although not
statistically significant, the frequency of SPIP among urine
samples with negative/equivocal dipstick test results was
higher for postnatal than antenatal urine samples (28 %
[25/89] vs. 16 % [7/43], respectively, P = 0.1933), suggest-
ing that false negative dipstick test results were more likely
to occur postpartum than antepartum.
Finally, the associations between reasons for the
first P/Cr test and P/Cr test results were examined
(Table 4). Reasons for the first P/Cr test were speci-
fied in 1028 (99.5 %) of the 1033 women enrolled in
the study. At the first P/Cr test, hypertension was
already confirmed in 222 (22 %) but not in 806
(78 %) of these 1028 women. Among women with
similar dipstick test results, the risk of having SPIP
was consistently and significantly higher for hyperten-
sive than for normotensive women: 18 % (14/77) vs.
3.2 % (8/251) for negative/equivocal dipstick test re-
sult, 47 % (26/55) vs. 8.7 % (37/425) for 1+ dipstick
test result, and 91 % (82/90) vs. 59 % (44/75) for ≥ 2+
dipstick test result. The risk of SPIP was 16 % (9/55)
for normotensive women with 1+ dipstick test result
on two successive antenatal care visits. It was notable
that [Cr] in the urine samples with ≥ 1+ on dipstick
test was significantly lower for hypertensive than
normotensive women.
Discussion
In this study population in which approximately 20, 7, and
12 % of women developed PE, gestational hypertension,lts
[P] (mg/dL) [Cr] (mg/dL)
18.3 (4.0–323)a 45.0 (11.0–194)a
5.0 (0.0–50.0) 69.5 (10.0–446)
42.0 (6.0–302)a 71.0 (8.7–286)a
19.0 (1.0–101) 165 (10.0–831)
100 (25.0–704)a 105 (18.0–312)a
28.0 (1.0–119) 202 (27.0–598)
331 (12.0–6170)a 128 (10.0–401)a
79.5 (46.0–113) 383 (259–507)
in pregnancy defined as P/C > 0.27
Fig. 2 Frequencies of SPIP, and of positive, false positive, and false
negative dipstick test results according to urinary creatinine
concentration. *, P < 0.05 vs. value of the 1st quintile group. This
analysis was performed in 1033 urine samples from 1033 women.
For women with available antenatal P/Cr test results (n = 1004), data
of the P/Cr test performed on the day closest to the day of delivery
were used. In women with availability of only postnatal P/Cr test
results (n = 29), data of the P/Cr test performed on the day closest
to the day of delivery were used. Urine specimens were grouped
into quintiles according to [Cr]: 1st quintile, [Cr] = 10.0–53.9 mg/dL;
2nd quintile, [Cr] = 54.0–90.0 mg/dL; 3rd quintile, [Cr] = 90.1–
133 mg/dL; 4th quintile, [Cr] = 133.1–190 mg/dL; and 5th quintile,
[Cr] = 190.1–606 mg/dL. False positive rates on dipstick test for
prediction of SPIP were 37.0 % (30/81), 39.4 % (43/109), 59.4 % (85/
143), 76.8 % (126/164), and 75.5 % (145/192) for the 1st, 2nd, 3rd,
4th, and 5th quintile groups, respectively. False negative rates on
dipstick test for prediction of SPIP were 10.7 % (14/131), 6.5 % (6/93),
3.0 % (2/67), 7.7 % (3/39), and 7.1 % (1/14) for the 1st, 2nd, 3rd, 4th,
and 5th quintile groups, respectively. The dipstick test gave false
positive results exclusively in all urine specimens with [Cr] > 500 mg/
dL for prediction of SPIP. The median (range) [P] increased with
increasing [Cr]; 5 (1.0–493), 12 (1.0–961), 17 (1.0–1103), 22 (1.0–1342),
and 28 (1.0–6170) mg/dL for the 1st, 2nd, 3rd, 4th, and 5th quintile
groups, respectively, while corresponding those for women with
positive dipstick test results were 27 (1.0–493) (n = 81), 27 (1.0–961)
(n = 109), 23 (1.0–1103) (n = 143), 23 (1.0–1342) (n = 164), and 30
(1.0–6170) (n = 192) mg/dL for the 1st, 2nd, 3rd, 4th, and 5th quintile
groups, respectively. Percentage of women with [P] ≥ 30 mg/dL
increased with increasing [Cr]; 19 % (40/212), 26 % (53/202), 28 %
(59/210), 28 % (57/203), and 49 % (100/208) for the 1st, 2nd, 3rd, 4th,
and 5th quintile groups, respectively
Table 3 Comparison between antenatal and postnatal urine
samples
Antenatal urine Postnatal urine
No. of specimens 178 178
GW at sampling 36.1 (10–41) NA
Days before delivery 2.5 (0–195) NA
Postpartum days at sampling NA 5.0 (0–63)
[P] (mg/dL) 86 (0.0–6170) 25.5 (1.0–648)a
[Cr] (mg/dL) 100 (10–401) 60 (8.7–297)a
Negative/equivocal dipstick test result
No. of specimens 43 89
[P] (mg/dL) 8.0 (0.0–56) 10.0 (1.0–193)
[Cr] (mg/dL) 68.0 (10.0–310) 55.0 (14.0–297)
P/Cr 0.09 (0.0–0.71) 0.17 (0.01–3.51)
SPIP (P/Cr > 0.27) 7 (16.3 %) 25 (28.1 %)
178 paired urine sample from 178 women were analyzed. GW, gestational
week; NA, not applicable; [P], protein concentration; [Cr], creatinine
concentration; and SPIP, significant proteinuria in pregnancy
a, P < 0.05 vs. antenatal samples
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were emphasized: (1) dipstick test results were closely re-
lated to [Cr], and false positive results were likely to occur
in concentrated urine samples with higher [Cr]; (2) post-
partum urine samples had significantly lower [Cr] com-
pared to antepartum urine samples; and (3) in comparison
between normotensive and hypertensive women with
similar dipstick test result, the risk of having SPIP was
consistently higher for hypertensive than normotensive
women at any dipstick test result. For example, among
women with a result of 1+ on dipstick test, SPIP waspresent in 47 vs. 8.7 % of hypertensive vs. normotensive
women, respectively. Even among women with negative or
equivocal dipstick test results, SPIP was present in as
many as 18 % of hypertensive women, while this rate was
3.2 % in normotensive women.
PE is a life-threatening complication [1] and hospital-
ized care is currently recommended for women diag-
nosed with this condition [17, 19]. As the dipstick test is
widely used for screening of SPIP, it is very important to
determine which women should undergo confirmation
tests, such as the P/Cr test, for diagnosis of SPIP. How-
ever, the frequency of false positive results on dipstick
test is high [8–10], as confirmed in the present study.
There have been only a few reports focusing on the as-
sociation between the results of dipstick and P/Cr tests
[9, 10]. Therefore, better characterization of the screen-
ing characteristics of the dipstick test according to vari-
ous clinical situations would help clinicians in prediction
of SPIP with this test.
This study confirmed that urine of pregnant women
had varied [Cr], ranging from 8.1 to 862 mg/dL (median,
105 mg/dL), suggesting that the kidneys are able to con-
centrate urine by approximately 100-fold in pregnancy.
In addition, it was clearly demonstrated that the false
positive rate on the dipstick test increased with increas-
ing [Cr] for prediction of SPIP (Fig. 2). All of six urine
samples with very high [Cr] > 500 mg/dL exhibited ex-
clusively false positive results on dipstick test (see leg-
ends for Figs. 1 and 2). Five of these six urine samples
were collected at earlier stages of pregnancy. It was
speculated that these women with extremely high [Cr]
suffered from hyperemesis and dehydration, and
Table 4 Association between reasons for first P/Cr test and P/Cr test results
P/Cr test result
Reason for the first time P/Cr test [P] [Cr] SPIP (P/Cr > 0.27)
After confirmation of hypertension onset (n = 222) with following dipstick test results:
Negative/equivocal (n = 77) 9 (1–323)a 66 (11–194) 14 (18 %)a
Positive with 1+ (n = 55) 25 (5–314)a 117(20–402)a 26 (47 %)a
Positive with≥ 2+ (n = 90) 185 (6–3890)a 133 (18–533)a 82 (91 %)a
No hypertension onset (n = 806) with following dipstick test results:
Negative/equivocal (n = 251) 4 (0–60) 63 (11–446) 8 (3.2 %)
Positive with 1+ (n = 425) 19 (1–196) 162 (10–708) 37 (8.7 %)
Positive with≥ 2+ (n = 75) 71 (1–866) 191 (27–598) 44 (59 %)
Positive with 1+ at two successive visits (n = 55) 21 (1–192) 146 (26–364) 9 (16 %)
The reason for the first P/Cr test was specified in 1028 of the 1033 women
[P], protein concentration; [Cr], creatinine concentration; and SPIP, significant proteinuria in pregnancy
a, P < 0.05 vs. corresponding value for the group without hypertension
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plained our clinical impression that a positive dipstick
test result was relatively common in women in early
stages of pregnancy. In this context, it may be important
to note that postpartum urine samples were more dilute
than those obtained antepartum (Table 3). A false nega-
tive dipstick test result was relatively common (approxi-
mately 11 %) in dilute urine samples with [Cr] < 54 mg/
dL (Fig. 2). The more dilute postpartum urine may be
explained as follows. Water retention occurs physiolo-
gically in normal pregnancy. The process involved in the
retention of water during pregnancy is reversed by par-
turition, and the excess water in the interstitial space
returns into the intravascular space, resulting in a fall in
hematocrit value [20] and the excess water is then ex-
creted as urine with lower [Cr] postpartum.
In this study, the risk of having SPIP among women
with similar results on dipstick test was significantly
higher for hypertensive than normotensive women at any
dipstick test result, including negative/equivocal test re-
sults (Table 4). To our knowledge, this is the first report of
this phenomenon, and it suggested that a false positive
dipstick test result was less likely in urine samples of
hypertensive women. As shown clearly in this study, the
dipstick test results were associated with [Cr] and the false
positive rate was lower in urine samples with lower [Cr].
Indeed, urine samples of hypertensive women were less
concentrated than those of normotensive women (Table 4),
suggesting that hypertension may affect renal function
with respect to urine concentration. In addition to the
mechanism underlying this phenomenon, it may be clinic-
ally important that women after confirmation of hyperten-
sion had significantly higher risk of SPIP at any dipstick
test result compared to those who remained normoten-
sive. In this population, the risks of SPIP were 18, 47, and
91 % for hypertensive women with negative/equivocal, 1+,and ≥ 2+ results on dipstick test, respectively. Correspond-
ing values were 3.2, 8.7, and 59 % for normotensive
women, respectively. These observations suggested that
hypertensive women with dipstick test result ≥ 1+ as well
as normotensive women with dipstick test result ≥ 2+
should be recommended to undergo a confirmation test
for SPIP.
In an earlier single-center study in pregnant women
with GW 30–36 who did not develop PE, as many as 28 %
of women exhibited a 1+ result on dipstick test at least
once, and 5.9 % of women exhibited 1+ on dipstick test at
two successive antenatal care visits [10]. In this study,
SPIP was confirmed in 8.7 % (37/425) of normotensive
women with a result of 1 + on dipstick test. This SPIP
prevalence rate increased to 16 % (9/55) in women with a
result of 1 + on dipstick test at two successive antenatal
care visits, which was somewhat lower than the value of
30 % reported previously [10]. However, based on these
results, women with a dipstick test result of 1 + at two
successive antenatal care visits appeared to have consider-
ably higher risk of SPIP compared to those with a dipstick
test result of 1 + only once. These women were also con-
sidered as candidates for confirmation test for SPIP.
Conclusion
Although the dipstick test may be appropriate for
screening of SPIP on the basis of both cost and rapidity,
the dipstick test was likely to show a false positive test
result with increasing [Cr]. However, women with con-
firmed hypertension were less likely to exhibit a false
positive test result on dipstick test compared to those
who remained normotensive. The risk of SPIP was 74 %
(108/145) in hypertensive women with urine samples
showing a dipstick test result ≥ 1+ (Table 4). Even in
normotensive women, the risk of SPIP was more than
50 % when their urine samples exhibited dipstick test
Baba et al. BMC Pregnancy and Childbirth  (2015) 15:331 Page 7 of 7results ≥ 2+. These results suggested that hypertensive
women with dipstick test results ≥ 1+ as well as normo-
tensive women with dipstick test results ≥ 2+ are candi-
dates for confirmation test for SPIP. In addition,
postpartum urine samples were more dilute than ante-
partum urine samples. It should be noted that false
negative results are relatively common in such urine
samples with lower [Cr].
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